The drugs currently approved for AD treatment include cholinesterase (ChE) inhibitors (galantamine rivastigmine), donepezil [131], and memantine, a non-competitive N-methyl-D-aspartate receptor antagonist [132]. The gene discussed is BCHE; the disease is Alzheimer disease.